XBI
$156.41SPDR S&P Biotech ETF
Equal-weight biotech stocks in the S&P Biotech Index.
Expense ratio
0.35%
Dividend yield
0.35%
AUM
$10.92B
Issuer
State Street
YTD return
28.80%
1Y return
—
5Y return
—
10Y return
—
Top holdings
Top holdings · XBI
| MRNA | Moderna Inc | 2.37% |
| NTRA | Natera Inc | 1.82% |
| HALO | Halozyme Therapeutics Inc | 1.77% |
| TWST | Twist Bioscience Corp | 1.77% |
| BIIB | Biogen Inc | 1.75% |
| AMGN | Amgen Inc | 1.73% |
| EXEL | Exelixis Inc | 1.73% |
| UTHR | United Therapeutics Corp | 1.72% |
| ABBV | AbbVie Inc | 1.71% |
| GILD | Gilead Sciences Inc | 1.70% |
Sector exposure
Sector breakdown · XBI
Financial Services0.6%
Healthcare99.3%